Evaluation of the OvarianTag biomarker panel's applicability in detecting Krukenberg tumors.
Authors:
- Ana Beatriz Ramos Do NascimentoANAna Beatriz Ramos Do Nascimento
- Eduardha Santos Temponi BarrosoEBEduardha Santos Temponi Barroso
- Anna Carolina Almeida de PaulaAPAnna Carolina Almeida de Paula
- Stephanie Braga Gonçalves da SilvaSSStephanie Braga Gonçalves da Silva
- Rafaela L Opes Figueiredo de AndradeRARafaela L Opes Figueiredo de Andrade
- Thalía Rodrigues de Souza ZózimoTZThalía Rodrigues de Souza Zózimo
- Aline Luiza Costa e SilvaASAline Luiza Costa e Silva
- Ramon De Alencar PereiraRPRamon De Alencar Pereira
- Pedro Henrique Villar DelfinoPDPedro Henrique Villar Delfino
- Paulo Guilherme De Oliveira SallesPSPaulo Guilherme De Oliveira Salles
- Jorge Gomes Goulart FerreiraJFJorge Gomes Goulart Ferreira
Open Access
- 23 October 2025
- journal article
- Published by Instituto Mário Penna in Mário Penna Journal
- Vol. 2 (2) , 29-40
Abstract
Krukenberg tumor is a metastatic ovarian adenocarcinoma, typically originating from the gastrointestinal tract, especially gastric cancer. It accounts for a significant proportion of ovarian tumors, being more common in Asian populations. These tumors usually affect younger women and have a poor prognosis. Diagnosis is challenging due to clinical similarities with other ovarian cancers, requiring a multimodal approach, including imaging tests, histopathological analysis, and biochemical markers. CA-125 may be useful in diagnosis but lacks specificity. Identifying molecular biomarkers specific to Krukenberg tumors could improve diagnosis and treatment. This study investigated the use of the OvarianTag® biomarker panel, developed to assess the prognosis of epithelial ovarian cancer (EOC), to differentiate between primary ovarian cancers and metastatic tumors from other sites, such as those from gastrointestinal origin. The research analyzed Krukenberg tumor samples and primary ovarian cancer samples, utilizing RNA extracted from tumor tissues and gene expression analysis by RT-qPCR. Despite genetic analysis, the OvarianTag® algorithm was unable to distinguish Krukenberg tumors from primary ovarian cancers accurately. The expression of genes TNFSRF10B, TNFSRF10C, and CASP8 showed no significant differences between the groups, and the algorithm failed to classify Krukenberg tumors correctly. These results suggest that OvarianTag® is not effective for this specific application, highlighting the need for new biomarkers to improve the diagnosis of metastatic ovarian tumors.Keywords
This publication has 13 references indexed in Scilit:
- Clinical Outcomes in Patients With Krukenberg Tumors From Colorectal CancerJournal of Surgical Research, 2024
- Evaluation of a decided sample size in machine learning applicationsBMC Bioinformatics, 2023
- The diagnosis and outcome of Krukenberg tumorsJournal of Gastrointestinal Oncology, 2021
- OvarianTag biomarker panel in order guide treatment decisions cisplatin-based for women with epithelial ovarian cancer.Journal of Clinical Oncology, 2020
- Caspase-8: The double-edged swordBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2020
- Treatments and overall survival in patients with Krukenberg tumorArchives of Gynecology and Obstetrics, 2019
- Clinical and genetic determinants of ovarian metastases from colorectal cancerCancer, 2016
- Desregulação da apoptose em neoplasias mieloproliferativas crônicasEinstein (São Paulo), 2013
- Comparação de três protocolos distintos para extração de RNA de amostras fixadas em formalina e emblocadas em parafinaJornal Brasileiro de Patologia e Medicina Laboratorial, 2011
- Immunohistochemistry in the distinction between primary and metastatic ovarian mucinous neoplasms: Table 1Journal of Clinical Pathology, 2011